{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:56:41Z","timestamp":1780725401101,"version":"3.54.1"},"reference-count":41,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["K119759, K129190, K135457"],"award-info":[{"award-number":["K119759, K129190, K135457"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GINOP","award":["2.3.2-15-2016-00050 \u201cPEPSYS\u201d"],"award-info":[{"award-number":["2.3.2-15-2016-00050 \u201cPEPSYS\u201d"]}]},{"name":"Hungarian Academy of Sciences MTA-TKI","award":["14016"],"award-info":[{"award-number":["14016"]}]},{"name":"Thematic Excellence Program 2021 Health Sub-programme of the Ministry for Innovation and Technology in Hungary, within the framework of the EGA-16 project of the P\u00e9cs of University, University of Pecs Medical School KA Research Grant","award":["KA-2019-30"],"award-info":[{"award-number":["KA-2019-30"]}]},{"name":"European Union's Horizon 2020 research and innovation program under grant agreement","award":["No 739593"],"award-info":[{"award-number":["No 739593"]}]},{"name":"\u2019National Heart Program","award":["NVKP_16-1-2016-0017"],"award-info":[{"award-number":["NVKP_16-1-2016-0017"]}]},{"name":"National Research, Development and Innovation Office (NKFIH) of Hungary","award":["FK134751"],"award-info":[{"award-number":["FK134751"]}]},{"name":"J\u00e1nos Bolyai Research Scholarships of the Hungarian Academy of Sciences","award":["."],"award-info":[{"award-number":["."]}]},{"name":"\u00daNKP-19-4 New National Excellence Program of the Ministry for Innovation and Technology","award":["\u00daNKP-19-4"],"award-info":[{"award-number":["\u00daNKP-19-4"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Pituitary adenylate cyclase activating polypeptide-38 (PACAP-38) is a multifunctional neuropeptide, which may play a role in cardioprotection. However, little is known about the presence of PACAP-38 in heart failure (HF) patients. The aim of our study was to measure the alterations of PACAP-38 like immunoreactivity (LI) in acute (n = 13) and chronic HF (n = 33) and to examine potential correlations between PACAP-38 and HF predictors (cytokines, NT-proBNP). Tissue PACAP-38 LI and PAC1 receptor levels were also investigated in heart tissue samples of patients with HF. Significantly higher plasma PACAP-38 LI was detected in patients with acute HF, while in chronic HF patients, a lower level of immunoreactivity was observed compared to healthy controls (n = 13). Strong negative correlation was identified between plasma PACAP-38 and NT-proBNP levels in chronic HF, as opposed to the positive connection seen in the acute HF group. Plasma IL-1 \u03b2, IL-2 and IL-4 levels were significantly lower in chronic HF, and IL-10 was significantly higher in patients with acute HF. PACAP-38 levels of myocardial tissues were lower in all end-stage HF patients and lower PAC1 receptor levels were detected in the primary dilated cardiomyopathy group compared to the controls. We conclude that PACAP-38 and PAC1 expression correlates with some biomarkers of acute and chronic HF; therefore, further studies are necessary to explore whether PACAP could be a suitable prognostic biomarker in HF patients.<\/jats:p>","DOI":"10.3390\/ijms23073715","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T21:44:52Z","timestamp":1648590292000},"page":"3715","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["PACAP-38 and PAC1 Receptor Alterations in Plasma and Cardiac Tissue Samples of Heart Failure Patients"],"prefix":"10.3390","volume":"23","author":[{"given":"D\u00f3ra","family":"Szab\u00f3","sequence":"first","affiliation":[{"name":"Heart Institute, Clinical Centre, Medical School, University of Pecs, 7624 Pecs, Hungary"},{"name":"Department of Anatomy, MTA-PTE PACAP Research Team, Centre for Neuroscience, Medical School, University of Pecs, 7624 Pecs, Hungary"},{"name":"Szentagothai Research Centre, University of Pecs, 7624 Pecs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"S\u00e1rszegi","sequence":"additional","affiliation":[{"name":"Heart Institute, Clinical Centre, Medical School, University of Pecs, 7624 Pecs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Be\u00e1ta","family":"Polg\u00e1r","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Immunology, Clinical Centre, Medical School, University of Pecs, 7624 Pecs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"S\u00e1ghy","sequence":"additional","affiliation":[{"name":"Cardiometabolic Research Group, MTA-SE System Pharmacology Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f3ra","family":"Regl\u0151di","sequence":"additional","affiliation":[{"name":"Department of Anatomy, MTA-PTE PACAP Research Team, Centre for Neuroscience, Medical School, University of Pecs, 7624 Pecs, Hungary"},{"name":"Szentagothai Research Centre, University of Pecs, 7624 Pecs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00fcnde","family":"T\u00f3th","sequence":"additional","affiliation":[{"name":"Department of Anatomy, MTA-PTE PACAP Research Team, Centre for Neuroscience, Medical School, University of Pecs, 7624 Pecs, Hungary"},{"name":"Szentagothai Research Centre, University of Pecs, 7624 Pecs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3746-8016","authenticated-orcid":false,"given":"Zs\u00f3fia","family":"On\u00f3di","sequence":"additional","affiliation":[{"name":"Cardiometabolic Research Group, MTA-SE System Pharmacology Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary"},{"name":"HCEMM-SU Cardiometabolic Immunology Research Group, Semmelweis University, 1089 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4529-2687","authenticated-orcid":false,"given":"Przemyslaw","family":"Leszek","sequence":"additional","affiliation":[{"name":"Department of Heart Failure and Transplantology, Cardinal Stefan Wyszy\u0144ski National Institute of Cardiology, 04-628 Warszawa, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2758-0784","authenticated-orcid":false,"given":"Zolt\u00e1n V.","family":"Varga","sequence":"additional","affiliation":[{"name":"Cardiometabolic Research Group, MTA-SE System Pharmacology Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary"},{"name":"HCEMM-SU Cardiometabolic Immunology Research Group, Semmelweis University, 1089 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Helyes","sequence":"additional","affiliation":[{"name":"Szentagothai Research Centre, University of Pecs, 7624 Pecs, Hungary"},{"name":"Department of Pharmacology and Pharmacotherapy, Medical School, University of Pecs, 7624 Pecs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Kem\u00e9ny","sequence":"additional","affiliation":[{"name":"Szentagothai Research Centre, University of Pecs, 7624 Pecs, Hungary"},{"name":"Department of Pharmacology and Pharmacotherapy, Medical School, University of Pecs, 7624 Pecs, Hungary"},{"name":"Department of Medical Biology, Medical School, University of Pecs, 7624 Pecs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Ferdinandy","sequence":"additional","affiliation":[{"name":"Cardiometabolic Research Group, MTA-SE System Pharmacology Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary"},{"name":"Pharmahungary Group, 6720 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tam\u00e1s","sequence":"additional","affiliation":[{"name":"Department of Anatomy, MTA-PTE PACAP Research Team, Centre for Neuroscience, Medical School, University of Pecs, 7624 Pecs, Hungary"},{"name":"Szentagothai Research Centre, University of Pecs, 7624 Pecs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"29590","DOI":"10.1038\/srep29590","article-title":"N-terminal pro b-type natriuretic peptide (NT-pro-BNP)-based score can predict in-hospital mortality in patients with heart failure","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"k1450","DOI":"10.1136\/bmj.k1450","article-title":"Diagnostic accuracy of point-of-care natriuretic peptide testing for chronic heart failure in ambulatory care: Systematic review and meta-analysis","volume":"361","author":"Taylor","year":"2018","journal-title":"BMJ"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Pan, W., Yang, D., Yu, P., and Yu, H. (2020). Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions. BMC Cardiovasc. Disord., 20.","DOI":"10.1186\/s12872-020-01493-2"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10741-010-9168-4","article-title":"Proinflammatory cytokines in heart failure: Double-edged swords","volume":"15","author":"Hedayat","year":"2010","journal-title":"Heart Fail. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/ejhf.942","article-title":"Immune mechanisms in heart failure","volume":"19","author":"Zhang","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1124\/pr.109.001370","article-title":"Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery","volume":"61","author":"Vaudry","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/br.2017.917","article-title":"Pituitary adenylate cyclase-activating polypeptide attenuates tumor necrosis factor-\u03b1-induced apoptosis in endothelial colony-forming cells","volume":"7","author":"Bian","year":"2017","journal-title":"Biomed. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ygcen.2006.12.006","article-title":"Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis","volume":"153","author":"Racz","year":"2007","journal-title":"Gen. Comp. Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.regpep.2007.09.015","article-title":"PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia\/reperfusion-induced cardiomyocyte apoptosis","volume":"145","author":"Racz","year":"2008","journal-title":"Regul. Pept."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Reglodi, D., and Tamas, A. (2016). Pituitary Adenylate Cyclase Activating Polypeptide\u2013PACAP, Springer. [1st ed.].","DOI":"10.1007\/978-3-319-35135-3"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1749-6632.2008.03635.x","article-title":"Effects of PACAP and preconditioning against ischemia\/reperfusion-induced cardiomyocyte apoptosis in vitro","volume":"1163","author":"Roth","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/138161211795049679","article-title":"Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis","volume":"17","author":"Seaborn","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0167-0115(02)00193-3","article-title":"The effect of pituitary adenylate cyclase activating polypeptide on cultured rat cardiocytes as a cardioprotective factor","volume":"109","author":"Sano","year":"2002","journal-title":"Regul. Pept."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1196\/annals.1317.029","article-title":"PACAP inhibits oxidative stress-induced activation of MAP kinase-dependent apoptotic pathway in cultured cardiomyocytes","volume":"1070","author":"Gasz","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12967-017-1189-5","article-title":"Analysis of necroptotic proteins in failing human hearts","volume":"15","author":"Szobi","year":"2017","journal-title":"J. Transl. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.toxlet.2019.02.013","article-title":"Oxidative stress injury in doxorubicin-induced cardiotoxicity","volume":"307","author":"Songbo","year":"2019","journal-title":"Toxicol. Lett."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1253\/circj.CJ-09-1024","article-title":"Cardioprotective effect of endogenous pituitary adenylate cyclase activating polypeptide on doxorubicin-induced cardiomyopathy in mice","volume":"74","author":"Mori","year":"2010","journal-title":"Circ. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.peptides.2017.07.007","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice","volume":"95","author":"Subramaniam","year":"2017","journal-title":"Peptides"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1161\/01.CIR.0000147235.53360.59","article-title":"Pulmonary hypertension and right heart failure in pituitary adenylate cyclase-activating polypeptide type I receptor-deficient mice","volume":"110","author":"Otto","year":"2004","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Szabo, D., Sarszegi, Z., Polgar, B., Saghy, E., Nemeth, A., Reglodi, D., Makkos, A., Gorbe, A., Helyes, Z., and Ferdinandy, P. (2021). PACAP-38 in acute ST-segment elevation myocardial infarction in humans and pigs: A translational study. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062883"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1161\/01.CIR.0000145158.33801.F3","article-title":"Ongoing myocardial injury in stable severe heart failure: Value of cardiac troponin T monitoring for high-risk patient identification","volume":"110","author":"Perna","year":"2004","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"170645","DOI":"10.1016\/j.peptides.2021.170645","article-title":"Changes of pituitary adenylate cyclase activating polypeptide (PACAP-38) level in polytrauma patients in the early post-traumatic period","volume":"146","author":"Tamas","year":"2021","journal-title":"Peptides"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s12031-017-1025-7","article-title":"Examination of pituitary adenylate cyclase-activating polypeptide (PACAP-38) as a potential biomarker in heart failure patients","volume":"68","author":"Sarszegi","year":"2019","journal-title":"J. Mol. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ejhf.1494","article-title":"Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations","volume":"21","author":"Mueller","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000076766","article-title":"Beta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1\/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure","volume":"11","author":"Gage","year":"2004","journal-title":"Neuroimmunomodulation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/sji.12328","article-title":"Effect of cardiac resynchronization therapy on inflammation in congestive heart failure: A review","volume":"82","author":"Mollnes","year":"2015","journal-title":"Scand. J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10741-018-9716-x","article-title":"Role of cytokines and inflammation in heart function during health and disease","volume":"23","author":"Bartekova","year":"2018","journal-title":"Heart Fail. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10557-020-07071-0","article-title":"Inflammatory cytokines and chemokines as therapeutic targets in heart failure","volume":"34","author":"Hanna","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_30","first-page":"2058739218818686","article-title":"Association of IL-1\u03b2 polymorphisms and plasma levels with chronic heart failure: A case-control study in Chinese patients","volume":"16","author":"Ji","year":"2018","journal-title":"Eur. J. Infl."},{"key":"ref_31","first-page":"8107","article-title":"Increased circulating interleukin 10-secreting B cells in patients with dilated cardiomyopathy","volume":"8","author":"Guo","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10741-013-9393-8","article-title":"Could interferon-gamma be a therapeutic target for treating heart failure?","volume":"19","author":"Levick","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","article-title":"Anti-TNF therapy against congestive heart failure investigators. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: Results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"ref_34","first-page":"253","article-title":"Effects of carvedilol on plasma levels of interleukin-6 and tumor necrosis factor-alpha in nine patients with dilated cardiomyopathy","volume":"39","author":"Matsumura","year":"2002","journal-title":"J. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s12031-012-9815-4","article-title":"PACAP-38 immunoreactivity in human malignant tumor samples and cardiac diseases","volume":"48","author":"Szanto","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.npep.2010.10.002","article-title":"Cardiac ischemia-reperfusion regulates sympathetic neuropeptide expression through gp130-dependent and independent mechanisms","volume":"45","author":"Alston","year":"2011","journal-title":"Neuropeptides"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"s45","DOI":"10.1016\/j.cardfail.2004.06.095","article-title":"Mortality in end stage heart failure is associated with paradoxically low NT-pro BNP and BNP levels: \u201cnatriuretic peptide exhaustion\u201d?","volume":"10","author":"Miller","year":"2004","journal-title":"J. Card. Fail."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1042\/CS20160170","article-title":"Molecular mechanisms in cardiomyopathy","volume":"131","author":"Dadson","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1161\/01.CIR.100.5.559","article-title":"Ischemic preconditioning in humans: Models, mediators, and clinical relevance","volume":"100","author":"Tomai","year":"1999","journal-title":"Circulation"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3389\/fphys.2017.00935","article-title":"Alternative splicing of NOX4 in the failing human heart","volume":"8","author":"Varga","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Baranyai, T., Herczeg, K., Onodi, Z., Voszka, I., Modos, K., Marton, N., Nagy, G., Mager, I., Wood, M.J., and El Andaloussi, S. (2015). Isolation of exosomes from blood plasma: Qualitative and quantitative comparison of ultracentrifugation and size exclusion chromatography methods. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0145686"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/7\/3715\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:45:11Z","timestamp":1760136311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/7\/3715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["ijms23073715"],"URL":"https:\/\/doi.org\/10.3390\/ijms23073715","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]}}}